M&A Deal Summary |
|
|---|---|
| Date | 2011-08-31 |
| Target | Astra Tech AB |
| Sector | Medical Products |
| Buyer(s) | Dentsply Sirona |
| Sellers(s) | AstraZeneca |
| Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1877 |
| Sector | Medical Products |
| Employees | 15,000 |
| Revenue | 4.0B USD (2023) |
Dentsply Sirona is a manufacturer and distributor of dental and other consumable healthcare products. Company broad global product platform helps dental professionals serve patients' oral health care for a lifetime, from preventive services to tooth replacement. DENTSPLY oral health products range from general dental consumables and laboratory products to products supporting the dental specialty markets of orthodontics, endodontics, and implants. Dentsply Sirona was founded in 1877 and is based in Charlotte, North Carolina.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 10 |
| Sector (Medical Products) | 3 of 7 |
| Type (Divestiture) | 1 of 1 |
| Country (Sweden) | 1 of 1 |
| Year (2011) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2000-07-11 |
Midwest Orthodontic Manufacturing
Columbus, Indiana, United States Midwest Orthodontic Manufacturing (MOM) produces a broad array of ancillary materials used in orthodontia from their ISO 9002 certified Indiana facility, including elastics, retainer cases and springs. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-11-22 |
Dentsply
Katikati, New Zealand Triodent was founded in 2003 by dentist and inventor Simon McDonald with the aim of manufacturing products that made the dentist’s job easier, with better outcomes for the patient. Dr McDonald’s first product was the Tri-Clip. He followed this in 2005 with the V-Ring – the first retainer ring with V-shaped tines and the first made from nickel-titanium. The V-Ring was named Top Matrix System by The Dental Advisor in 2008. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1992 |
| Sector | Life Science |
| Employees | 83,100 |
| Revenue | 45.8B USD (2023) |
AstraZeneca is a global biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in several major disease areas, including oncology, cardiovascular, renal & metabolism, and respiratory & immunology. The Company's aim is to improve the health and quality of life of patients around the world through medicines, treatment solutions, and accessibility to healthcare. AstraZeneca is involved in both the research and development (R&D) and manufacturing of drugs to address critical areas of unmet medical need. AstraZeneca was founded in 1992 and is based in Cambridge, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 11 |
| Sector (Medical Products) | 1 of 3 |
| Type (Divestiture) | 2 of 11 |
| Country (Sweden) | 2 of 2 |
| Year (2011) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-11-17 |
AstraZeneca - Biotech Laboratory
Södertälje, Sweden AstraZeneca - Biotech Laboratory engages in research of proteins produced by disease genes. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-06-19 |
Ardea Biosciences
Lafayette, California, United States Ardea Biosciences, Inc. in a reverse merger transaction. IntraBiotics Pharmaceuticals, Inc. does not have significant operations. |
Buy | $1.3B |
